Get in Touch

To understand the key regulatory and competitive landscape changes that could impact a South Korean drug launch.

  • Access Strategy

Client Challenge

With potential upcoming regulatory changes, the client needed to understand the implications of this legislation on a possible drug launch. The impact of competitors also needed to be analysed and considered in relation to the regulatory changes.

This information would then be used to help inform the launch strategy in South Korea.

P4A Solution

Several possible scenarios were explored with regulatory and payer experts.

After completing secondary market research, P4A tested key questions with five South Korean experts covering HTA and regulatory perspectives. This information was used to build the launch strategy and recommendations.

The Successful Outcome​

Mapping of potential launch scenarios – the interaction between legislation and competition was mapped in detail.

Launch recommendation – the optimal route to market was plotted, as well as mitigation strategies should a less desirable scenario develop.

Need more details?

Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?

get in touch

Explore other case studies

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Price Optimisation, Access Strategy
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact

P4A Services

For all access and Rare Disease related overview enquiries